返回 Agenda
Mergers & Acquisitions – The Multinational Pharma Quagmire
Session Chair(s)
Moin Don
Founder and CEO, PVCON Consulting, Lead: South Asia Chapter (ISoP),, International Society of Pharmacovigilance (ISoP), India
Mergers & Acquisitions (M&A) within pharma companies has become a regular phenomenon and needs deeper analysis to understand its dynamics. During M&A, it is not only the PV domain which needs critical attention from a management perspective but equally important are others functions such as Legal/Regulatory Affairs/ Safety Database/ Change in QPPV &PSMF, etc. This session shall explore encompassing all such challenges faced by pharma companies during M&A process.
Speaker(s)
Seema Jaitly, DrMed
Managing Director, Sagittal Pharma Consulting Ltd, United Kingdom
Contributing Panelist
Amit Patil, PHARMD
Sr. Manager, Regulatory Affairs, Pfizer Limited, India
Contributing Panelist
Preeti Verma
Senior Director, Solution Architect Leader, Business Development,, Qinecsa Solutions , United States
Contributing Panelist
Gaurav Shah
Deputy General Manager, Product Safety and Risk Management, Viatris Laboratories Ltd, India
Contributing Panelist
Gaurang Shah
Proprietor, GAURANG SHAH & ASSOCIATES, India
Contributing Panelist